Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
RapidPulse secures $48M in oversubscribed Series B funding co-led by Medtronic and TechWald Next S.p.A. to advance its next-generation stroke aspiration technology.
PRIVATEJul 16, 2026•24 days ago
Amount Raised
$48 Million
Round Type
Series B
MiamiInformation TechnologyInvestors
Epidarex CapitalHatteras Venture PartnersSyntheonSanté VenturesFlorida Opportunity FundSbi Investment Company Ltd.S3 VenturesTech Wald Next S.P.A.Medtronic
Description
RapidPulse, Inc. announces the close of a $48 million Series B financing to support its Investigational Device Exemption study. The financing drew substantial interest, co-led by Medtronic and TechWald Next S.p.A. This funding will enable the company to expand its clinical experience and seek FDA approval
Funding Insights
Based on industry dataTimeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech